Global epidemiology of HIV infection and AIDS

Clinics in Dermatology

Volumn 18, Issue 4, 2000, Pages 381-387

  Stratigos, John D ^a   Tzala, Evangelia ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Hellenic Centre for Infectious Diseases Control   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ASIA; CENTRAL AMERICA; EPIDEMIC; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE EAST; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; SOUTH ASIA; SOUTHEAST ASIA; WESTERN HEMISPHERE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMAN; WORLD HEALTH;

EID: 0033832652     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00133-9     Document Type: Review

References (43)

1. UNAIDS-WHO. Improving estimates. Report on the global HIV/AIDS epidemic, June 1998.
2. Fowler M.G., Melnick S.L., Mathieson B.J. Women and HIV. Epidemiology and global overview. Obstet Gynecol Clin North Am. 24:1997;705-729.
3. Boerma J.T., Nunn A.J., Whitworth J.A. Mortality impact of the AIDS epidemic Evidence from community studies in less developed countries . AIDS. 12:(Suppl 1):1998;S3-S14.
4. Timaeus I. Impact of the HIV epidemic on mortality in sub-Saharan Africa Evidence from national surveys and censuses . AIDS. 12:(Suppl 1):1998;S15-S27.
5. UNAIDS-WHO. HIV and mortality. Report on the global HIV/AIDS epidemic, June 1998.
6. Nunn A.J., Mulder D.W., Kamali A., et al. Mortality associated with HIV-1 infection over five years in a rural Ugandan population Cohort Study . BMJ. 315:1997;767-771.
7. UNAIDS-WHO. Report on the global HIV/AIDS epidemic, December 1997.
8. Grosskurth H., Mosha F., Todd J., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania Randomized controlled trial . Lancet. 346:1995;530-536.
9. WHO. HIV/AIDS. The global epidemic, December 1996. Wkly Epidemiol Rec 199;72:17-21.
10. Davison K., Nicoll A. The changing global epidemiology of HIV infection and AIDS. Commun Dis Rep CDR Wkly. 7:1997;R134-R136.
11. Mertens T.E., Belsey E., Stoneburner R.L. Global estimates and epidemiology of HIV-1 infections and AIDS Further heterogeneity in spread and impact . AIDS. 9:(Suppl A):1995;S259-S272.
12. UNAIDS-WHO. HIV/AIDS estimates and indicators, end 1997. Report on the global HIV/AIDS epidemic, June 1998.
13. UNAIDS-WHO. HIV and AIDS: The global situation. Report on the global HIV/AIDS epidemic, June 1998.
14. STD/AIDS Control Programme at Ministry of Health, Uganda. A report on declining trends in HIV infection rates in sentinel surveillance sites in Uganda. Kampala: Ministry of Health, 1996.
15. Monitoring the AIDS Pandemic (MAP). Final report on the status and trends of the HIV/AIDS/STD epidemics in Asia and the Pacific. Official Symposium of the 4th International Conference on AIDS in Asia and the Pacific. October 25-29, 1997, Manila, Philippines.
16. UNAIDS-WHO. The evolving picture region by region. Report on the global HIV/AIDS, June 1998.
17. Lalvani A., Shastri J.S. HIV epidemics in India Opportunity to learn from the past . Lancet. 347:1996;1349-1350.
18. Nelson K.E., Celentano D.D., Eiumtrakol S., et al. Changes in sexual behaviour and a decline in HIV infection among young gay men in Thailand. N Engl J Med. 335:1996;297-303.
19. Carvalheiro CD, Manco AR. Mortality among women for reproductive age in an urban area of the south-eastern region of Brazil. Evolution in the past 20 years. Rev Saude Publica 1992;Aug 26:239-45.
20. CDC. US HIV and AIDS cases reported through December 1997. HIV/AIDS Surveillance Report 1997;9:1-38.
21. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: Quarterly report no. 57. Saint-Maurice: WHO-EU, 1998.
22. Hamers F.F., Downs A.M., Infuso A., et al. Diversity of the HIV/AIDS epidemic in Europe. AIDS. 12:(Suppl A):1998;S63-S70.
23. Hamers F.F., Batter V., Downs A.M., et al. The HIV epidemic associated with IDU in Europe Geographic and time trends . AIDS. 11:1997;1365-1374.
24. Gromyko A. Sexually transmitted diseases epidemic in eastern Europe A call for help . Entre Nous. 33:1996;7-8.
25. Tichonova L., Borisenko K., Ward H., et al. Epidemics of syphilis in the Russian Federation Trends, origins, and priorities for control . Lancet. 350:1997;210-213.
26. Hogg R.S., O'Shaughnessy M.V., Gataric N., et al. Decline in deaths from AIDS due to antiretrovirals (letter). Lancet. 49:1997;1294.
27. Hogg R.S., Heath K.V., Yip B., et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 279:1998;450-454.
28. Palella F.J. Jr, Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 338:1998;853-860.
29. Carpenter C.C., Fischl M.A., Hammer S.M., et al. Antiretroviral therapy for HIV infection in 1996 Recommendations of an international panel . International AIDS Society-USA. JAMA. 276:1996;146-154.
30. Therapeutic guidelines for the treatment of HIV/AIDS and related conditions. Vancouver: BC Centre for Excellence in HIV/AIDS, 1995.
31. Gostin L.O., Ward J.W., Baker A.C. National HIV case reporting for the United States - a defining moment in the history of the epidemic (letter). N Engl J Med. 337:1997;1162-1167.
32. Centers for Disease Control and Prevention. Update: Trends in AIDS incidence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:861-7.
33. European Centre for the Epidemiological Monitoring of AIDS: AIDS Surveillance in Europe. AIDS/HIV reporting in Europe. Quarterly Report No. 32. Saint-Maurice: European Centre for the Epidemiological Monitoring of AIDS; 1991.
34. CDC Advisory Committee on the Prevention of HIV Infection. External review of CDC's HIV prevention strategies. Atlanta, Georgia: Centers for Disease Control and Prevention, 1994.
35. Strategic plan for preventing human immunodeficiency virus (HIV) infection. Atlanta, Georgia: Centers for Disease Control and Prevention, 1992.
36. Position statement: Confidential reporting of HIV infection. Atlanta, Georgia: Council of State and Territorial Epidemiologists, 1997.
37. Ward J.W., Fleming P.L., Buehler J.W. Annotation What will be the role of HIV infection reporting? Am J Public Health. 84:1994;1888-1889.
38. Hogg R.S., Weber A.E., Craib K.J.P., et al. One world, on hope The cost of providing antiretroviral therapy to all nations . AIDS. 12:1998;2203-2209.
39. Connor E.M., Sperling R.S., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 331:1994;1173-1180.
40. Mansergh G., Haddix A.C., Steketee R.W., et al. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA. 276:1996;139-145.
41. Bulterys M., Lepage P. Mother-to-child transmission of HIV. Curr Opin Pediatr. 10:1998;143-150.
42. Stimson G.V. AIDS and injecting drug use in the United Kingdom, 1987-1993 The policy response and the prevention of the epidemic . Soc Sci Med. 41:1995;699-716.
43. Celentano D.D., Nelson K.E., Lyles C.M., et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men Evidence for success of the HIV/AIDS control and prevention program . AIDS. 12:1998;F29-F36.